Sinéad Toomey

3.0k total citations · 1 hit paper
66 papers, 2.0k citations indexed

About

Sinéad Toomey is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sinéad Toomey has authored 66 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 24 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sinéad Toomey's work include HER2/EGFR in Cancer Research (20 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Advanced Breast Cancer Therapies (10 papers). Sinéad Toomey is often cited by papers focused on HER2/EGFR in Cancer Research (20 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Advanced Breast Cancer Therapies (10 papers). Sinéad Toomey collaborates with scholars based in Ireland, United States and United Kingdom. Sinéad Toomey's co-authors include Orina Belton, Desmond J. Fitzgerald, Helen M. Roche, Dolores J. Cahill, Gerard Cagney, Thomas Kislinger, James McRedmond, Patricia B. Maguire, Judith A. Coppinger and Andrew Emili and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Sinéad Toomey

64 papers receiving 2.0k citations

Hit Papers

Characterization of the proteins released from activated ... 2003 2026 2010 2018 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sinéad Toomey Ireland 19 714 494 318 301 253 66 2.0k
Kathrin Eller Austria 30 666 0.9× 442 0.9× 175 0.6× 307 1.0× 292 1.2× 138 3.2k
Dale G. Hoyt United States 25 906 1.3× 717 1.5× 229 0.7× 129 0.4× 319 1.3× 46 2.3k
W. van Duijn Netherlands 23 772 1.1× 387 0.8× 191 0.6× 105 0.3× 242 1.0× 32 2.3k
Claudio Denzlinger Germany 24 546 0.8× 377 0.8× 132 0.4× 235 0.8× 249 1.0× 67 2.0k
Allan S. Pollock United States 25 805 1.1× 275 0.6× 110 0.3× 229 0.8× 231 0.9× 39 2.0k
Huan Deng China 23 692 1.0× 321 0.6× 65 0.2× 138 0.5× 200 0.8× 84 1.7k
Shigang Xiong United States 24 1.1k 1.6× 241 0.5× 241 0.8× 306 1.0× 177 0.7× 37 2.9k
Gregory Kouraklis Greece 32 1.2k 1.7× 737 1.5× 175 0.6× 99 0.3× 444 1.8× 142 3.1k
Shinya Abe Japan 23 718 1.0× 239 0.5× 71 0.2× 167 0.6× 335 1.3× 90 1.9k
Eitaro Taniguchi Japan 27 832 1.2× 422 0.9× 226 0.7× 122 0.4× 82 0.3× 66 2.9k

Countries citing papers authored by Sinéad Toomey

Since Specialization
Citations

This map shows the geographic impact of Sinéad Toomey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinéad Toomey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinéad Toomey more than expected).

Fields of papers citing papers by Sinéad Toomey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sinéad Toomey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinéad Toomey. The network helps show where Sinéad Toomey may publish in the future.

Co-authorship network of co-authors of Sinéad Toomey

This figure shows the co-authorship network connecting the top 25 collaborators of Sinéad Toomey. A scholar is included among the top collaborators of Sinéad Toomey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sinéad Toomey. Sinéad Toomey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Keelan, Stephen, et al.. (2024). Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease. Breast Cancer Research and Treatment. 207(3). 471–476. 4 indexed citations
3.
Fay, Joanna, Lance Hudson, Adrian Murphy, et al.. (2024). Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models. International Journal of Molecular Sciences. 25(24). 13264–13264. 9 indexed citations
4.
Hennessy, Bryan T., et al.. (2023). Synergistic effects of alpelisib (PI3K inhibitor) and ribociclib (CDK4/6 inhibitor) combination in preclinical colorectal cancer models.. Journal of Clinical Oncology. 41(4_suppl). 167–167. 1 indexed citations
5.
Keelan, Stephen, et al.. (2023). Efficacy and Safety of Trastuzumab Deruxtecan in Breast Cancer: A Systematic Review and Meta-Analysis. Clinical Breast Cancer. 23(8). 847–855.e2. 16 indexed citations
6.
Horgan, Denis, Tanja Čufer, Francesco Gatto, et al.. (2022). Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring. Healthcare. 10(9). 1714–1714. 21 indexed citations
7.
Toomey, Sinéad, Stephen F. Madden, Michelle Casey, et al.. (2020). Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19). Thorax. 76(1). 86–88. 57 indexed citations
8.
Creevey, Laura, Stephen F. Madden, Sinéad Toomey, et al.. (2019). Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy. Molecular Cancer Therapeutics. 18(10). 1731–1743. 9 indexed citations
11.
Toomey, Sinéad, Stephen F. Madden, Simon J. Furney, et al.. (2016). The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer. Oncotarget. 7(46). 75518–75525. 10 indexed citations
12.
Eustace, Alex J., Sinéad Toomey, Joanna Fay, et al.. (2016). The clinical impact of early immunological responses in human HER2-positive breast cancers on responsiveness to trastuzumab-based therapy.. Journal of Clinical Oncology. 34(15_suppl). 587–587. 1 indexed citations
14.
Flanagan, Lorna, Andreas U. Lindner, Joanna Fay, et al.. (2014). BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer. Journal of Molecular Medicine. 93(3). 315–326. 12 indexed citations
15.
Elamin, Yasir Y., Shereen Rafee, Sinéad Toomey, & Bryan T. Hennessy. (2014). Immune Effects of Bevacizumab: Killing Two Birds with One Stone. Cancer Microenvironment. 8(1). 15–21. 44 indexed citations
16.
Morine, Melissa J., Audrey Tierney, Ben van Ommen, et al.. (2011). Transcriptomic Coordination in the Human Metabolic Network Reveals Links between n-3 Fat Intake, Adipose Tissue Gene Expression and Metabolic Health. PLoS Computational Biology. 7(11). e1002223–e1002223. 27 indexed citations
17.
Oliver, Elizabeth, Fiona C. McGillicuddy, Catherine M. Phillips, Sinéad Toomey, & Helen M. Roche. (2010). The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chainn-3 PUFA. Proceedings of The Nutrition Society. 69(2). 232–243. 106 indexed citations
18.
Morine, Melissa J., Jolene McMonagle, Sinéad Toomey, et al.. (2010). Bi-directional gene set enrichment and canonical correlation analysis identify key diet-sensitive pathways and biomarkers of metabolic syndrome. BMC Bioinformatics. 11(1). 499–499. 15 indexed citations
19.
Toomey, Sinéad, Jolene McMonagle, & Helen M. Roche. (2006). Conjugated linoleic acid: a functional nutrient in the different pathophysiological components of the metabolic syndrome?. Current Opinion in Clinical Nutrition & Metabolic Care. 9(6). 740–747. 25 indexed citations
20.
Schneider, E, et al.. (1995). Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood. 85(1). 186–193. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026